Search

Your search keyword '"Zambon"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Zambon" Remove constraint Author: "Zambon" Journal atherosclerosis Remove constraint Journal: atherosclerosis
179 results on '"Zambon"'

Search Results

1. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

Catalog

Books, media, physical & digital resources

4. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

5. Efficacy and safety of lomitapide in familial chylomicronaemia syndrome

6. Coronary plaque burden, plaque characterization and their prognostic implications in familial hypercholesterolemia: A computed tomographic angiography study

7. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

9. VEGFR2 and OPG genes modify the risk of subclinical coronary atherosclerosis in patients with familial hypercholesterolemia

11. Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – analysis of patient-level LDL-C reduction, fat soluble vitamins, lipoproteins and patient maturation from APH-19 study

12. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

13. Lomitapide for the treatment of paediatric homozygous familial hypercholesterolaemia patients - Results from the efficacy phase of the APH-19 study

14. Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome (FCS): Data from the LOCHNES study

15. Novel missense variants in the LMF1 gene: Identification by next generation sequencing and functional characterization

19. Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

20. Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group

23. Post prandial metabolism of lipoproteins in familial chylomicronemia patients treated with lomitapide and tiparvovec

27. Association of single measurement of estimated glomerular filtration rate and non-quantitative dipstick proteinuria with all-cause and cardiovascular mortality in the elderly. Results from the Progetto Veneto Anziani (Pro.V.A.) Study

30. The spoils of war and the long-term spoiling of health conditions of entire nations

36. Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

40. Coronary artery calcium score and safeheart-risk equation for risk stratification in primary prevention familial hypercholesterolemia.